Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.5 INR | +1.96% | -8.83% | -12.82% |
Valuation
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 328.2 | 227.7 | 93.67 | 113.2 | 184.1 | 135.9 |
Enterprise Value (EV) 1 | 574 | 373.1 | 228 | 234 | 257.1 | 189.3 |
P/E ratio | 3.54 x | 8.05 x | -29.4 x | 83.7 x | 1.88 x | 4.93 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 0.64 x | 0.52 x | 0.3 x | 0.51 x | 1.31 x | 0.88 x |
EV / Revenue | 1.11 x | 0.86 x | 0.73 x | 1.05 x | 1.83 x | 1.22 x |
EV / EBITDA | 6.53 x | 10.8 x | 24.1 x | 8.05 x | -35.2 x | 135 x |
EV / FCF | -10.2 x | 4.41 x | 16.1 x | -63.9 x | -4.44 x | -11.5 x |
FCF Yield | -9.76% | 22.7% | 6.22% | -1.57% | -22.5% | -8.7% |
Price to Book | -2.02 x | -2.2 x | -0.88 x | -1.1 x | -33.7 x | 6.28 x |
Nbr of stocks (in thousands) | 4,880 | 6,505 | 6,505 | 6,505 | 6,505 | 6,505 |
Reference price 2 | 67.25 | 35.00 | 14.40 | 17.40 | 28.30 | 20.90 |
Announcement Date | 14/08/18 | 04/09/19 | 08/09/20 | 31/07/21 | 06/09/22 | 06/09/23 |
Income Statement Evolution (Annual data)
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 516.1 | 434.4 | 314 | 223.2 | 140.6 | 154.8 |
EBITDA 1 | 87.96 | 34.54 | 9.455 | 29.06 | -7.311 | 1.401 |
EBIT 1 | 77.8 | 24.35 | -1.063 | 19.24 | -9.166 | 0.06 |
Operating Margin | 15.07% | 5.6% | -0.34% | 8.62% | -6.52% | 0.04% |
Earnings before Tax (EBT) 1 | 76.56 | 26.22 | -14.81 | 1.957 | 97.96 | 30.8 |
Net income 1 | 76.56 | 26.22 | -3.175 | 1.353 | 97.96 | 27.57 |
Net margin | 14.83% | 6.04% | -1.01% | 0.61% | 69.69% | 17.81% |
EPS 2 | 19.01 | 4.348 | -0.4900 | 0.2080 | 15.06 | 4.238 |
Free Cash Flow 1 | -56.04 | 84.55 | 14.17 | -3.664 | -57.9 | -16.48 |
FCF margin | -10.86% | 19.46% | 4.51% | -1.64% | -41.19% | -10.65% |
FCF Conversion (EBITDA) | - | 244.79% | 149.91% | - | - | - |
FCF Conversion (Net income) | - | 322.44% | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 14/08/18 | 04/09/19 | 08/09/20 | 31/07/21 | 06/09/22 | 06/09/23 |
Balance Sheet Analysis
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 246 | 145 | 134 | 121 | 73 | 53.3 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 2.795 x | 4.212 x | 14.21 x | 4.158 x | -9.983 x | 38.08 x |
Free Cash Flow 1 | -56 | 84.5 | 14.2 | -3.66 | -57.9 | -16.5 |
ROE (net income / shareholders' equity) | -34% | -19.8% | 3.03% | -1.29% | -180% | 340% |
ROA (Net income/ Total Assets) | 15.5% | 5.25% | -0.28% | 6.2% | -3.55% | 0.02% |
Assets 1 | 494 | 499.7 | 1,146 | 21.81 | -2,759 | 1,12,992 |
Book Value Per Share 2 | -33.20 | -15.90 | -16.30 | -15.90 | -0.8400 | 3.330 |
Cash Flow per Share 2 | 1.420 | 1.520 | 0.7000 | 0.3500 | 0.5700 | 0.6500 |
Capex 1 | 5.71 | 7.72 | 7.82 | 0.37 | 20.4 | - |
Capex / Sales | 1.11% | 1.78% | 2.49% | 0.17% | 14.55% | - |
Announcement Date | 14/08/18 | 04/09/19 | 08/09/20 | 31/07/21 | 06/09/22 | 06/09/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
- Stock Market
- Equities
- 507759 Stock
- Financials Lime Chemicals Limited